Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,339 | -20,659 | -35,152 | -20,507 | -11,428 |
| Depreciation Amortization | 1,861 | 1,580 | 1,244 | 703 | 297 |
| Accounts receivable | -1,138 | -4,423 | -2,479 | 1,199 | 311 |
| Accounts payable and accrued liabilities | 2,859 | -3,495 | 2,688 | 2,529 | 725 |
| Other Working Capital | 3,741 | -13,677 | 1,359 | 2,335 | -1,488 |
| Other Operating Activity | 1,821 | 12,475 | 6,005 | -1,227 | 1,109 |
| Operating Cash Flow | $-15,195 | $-28,199 | $-26,333 | $-14,968 | $-10,473 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,000 | 6,000 | 24,000 | 24,000 | 12,000 |
| PPE Investments | -4,880 | -5,643 | -4,663 | -2,743 | -3,257 |
| Purchase Of Investment | 0 | -15,038 | N/A | -21,130 | -30,166 |
| Purchase Sale Intangibles | -127 | -1,043 | -990 | -420 | -245 |
| Other Investing Activity | -127 | -1,043 | -990 | -420 | -245 |
| Investing Cash Flow | $9,993 | $-15,724 | $18,347 | $-293 | $-21,668 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 101 | 42,882 | 3,105 | 2,327 | 64,908 |
| Other Financing Activity | -84 | -88 | -154 | -104 | -29 |
| Financing Cash Flow | $17 | $42,794 | $2,951 | $2,223 | $64,879 |
| Exchange Rate Effect | 1 | -1 | -3 | 9 | 1 |
| Beginning Cash Position | 32,899 | 34,029 | 39,067 | 52,097 | 19,358 |
| End Cash Position | 27,715 | 32,899 | 34,029 | 39,067 | 52,097 |
| Net Cash Flow | $-5,184 | $-1,130 | $-5,038 | $-13,030 | $32,739 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,195 | -28,199 | -26,333 | -14,968 | -10,473 |
| Capital Expenditure | -4,880 | -5,643 | -4,663 | -2,743 | -3,257 |
| Free Cash Flow | -20,075 | -33,842 | -30,997 | -17,712 | -13,730 |